Life Sciences/Biotech

$1 Billion Tax Credit To Support Biomedical Research By Small Firms

GRAND RAPIDS - Small biotechnology firms will be gaining new support in the state of Michigan. A New Therapeutic Discovery tax credit, created under the Affordable Care Act, will support research with potential to produce new therapies, create high-quality jobs for the state. The biotechnology industry employs 1.3 million Michigan workers, and the industry continues

By |2010-08-16T00:00:00-04:00August 16th, 2010|Archive, Life Sciences/Biotech|

Wayne State Professor Gets $1.7 Million NIH Grant To Study Kidney Diseases

DETROIT - Tej K. Mattoo, M.D., professor and chief of Pediatric Nephrology at Wayne State University's School of Medicine and Children's Hospital of Michigan, recently received more than $1.7 million from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to continue the project, Primary Vesicoureteral Reflux in

By |2010-08-13T00:00:00-04:00August 13th, 2010|Archive, Life Sciences/Biotech|

NanoBio Awarded Seventh U.S. Patent

ANN ARBOR ? NanoBio Corporation announced Tuesday that it has been awarded a seventh U.S. patent covering its novel nanoemulsion technology. The new claims encompass methods of treating Herpes Simplex I infections, including herpes labialis (commonly referred to as cold sores), using NanoBio's proprietary anti-infective nanoemulsion product candidates. This new patent covers NanoBio?s NB-001, a

By |2010-08-03T00:00:00-04:00August 3rd, 2010|Archive, Life Sciences/Biotech|

UM Chemist Wins $200K Award From McKnight Endowment Fund

ANN ARBOR - University of Michigan analytical chemist Robert T. Kennedy is one of four scientists selected to receive the 2010 Technological Innovations in Neuroscience Award from the McKnight Endowment Fund for Neuroscience. Kennedy, who is the Hobart H. Willard Professor of Chemistry and a professor of pharmacology, will receive $200,000 over two years to

By |2010-08-03T00:00:00-04:00August 3rd, 2010|Archive, Life Sciences/Biotech|

CMU Adds Laser Scanning Confocal Microscope For Genetics Research

MOUNT PLEASANT - Central Michigan University students and faculty who conduct research in genetics, neuroscience or biology in labs across campus now have one more tool to advance their studies. The Laser Scanning Confocal Microscope - a $450,000 microscope unit paired with a high-tech computer - provides not only better precision but also more opportunities

By |2010-07-19T00:00:00-04:00July 19th, 2010|Archive, Life Sciences/Biotech|

Pittsburgh Fund To Invest $20 Million In Life Sciences Startups In SE Michigan

PITTSBURGH - A Pittsburgh-based investment firm, iNetworks Advisors Inc., has announced a $20 million fund to invest in startup and early-stage health and life science companies in Southeast Michigan and Windsor. The fund, iNetworksMichigan Fund LP, which already has about $15 million in commitments. It also has appointed Greg Auner, director of the Smart Sensors

By |2010-07-18T00:00:00-04:00July 18th, 2010|Archive, Life Sciences/Biotech|

Second Patient-Care Academy Booked For October At Kalamazoo Valley CC

KALAMAZOO - A second edition of Kalamazoo Valley Community College's Patient Care Academy, which trains people for entry-level positions in the growing health-care industry while introducing them to the possibility of career enhancement in its various fields, is scheduled to begin on Oct. 2. The first academy is under way at the M-TEC located on

By |2010-07-13T00:00:00-04:00July 13th, 2010|Archive, Life Sciences/Biotech|

Diplomat Specialty Pharmacy Hires Vice President of Operations

SWARTZ CREEK - Diplomat Specialty Pharmacy, the nation's largest privately owned specialty pharmacy, announced Monday that Robert Fleckenstein will serve as the Vice President of Operations overseeing the day-to-day operations of Diplomat's National Distribution Center, Patient Service Operations, Call Center, Oncology Department and other patient facing services at Diplomat's Corporate headquarters. Because of Fleckenstein's prior

By |2010-07-13T00:00:00-04:00July 13th, 2010|Archive, Life Sciences/Biotech|

Perrigo Gets Exclusive Store Brand Rights To Allegra, Allegra D-12

ALLEGAN - Perrigo Tuesday announced that it has acquired the exclusive U.S. store brand rights to sell and distribute OTC versions of Fexofenadine HCl 180 mg and 60 mg tabs, plus Fexofenadine HCl 60 mg and Pseudoephedrine 120 mg tabs, the generic versions of Sanofi-Aventis' Allegra and Allegra D-12 products. Teva Pharmaceutical Industries Ltd. TEVA

By |2010-06-29T00:00:00-04:00June 29th, 2010|Archive, Life Sciences/Biotech|